Chemistry: analytical and immunological testing – Heterocyclic carbon compound – Hetero-n
Reexamination Certificate
2011-07-12
2011-07-12
Kim, Vickie (Department: 1777)
Chemistry: analytical and immunological testing
Heterocyclic carbon compound
Hetero-n
C435S004000, C435S007900
Reexamination Certificate
active
07977110
ABSTRACT:
A method for distinguishing between kidney dysfunctions in a mammal, including pre-renal azotemia, an acute renal injury that may progress to acute renal failure, and chronic kidney disease, using a urinary or circulating NGAL assay result that is compared to a predetermined NGAL cutoff level, and a single serum or plasma creatinine measurement. Typically the single creatinine measurement cannot distinguish acute renal injury from chronic kidney disease or pre-renal azotemia, a single measurement of urinary NGAL, combined with the single serum or plasma creatinine measurement, has sufficient sensitivity and specificity to distinguish acute renal injury from normal function, prerenal azotemia, and chronic kidney disease and predicts poor inpatient outcomes. Patients admitted to the emergency department of the hospital with any of acute kidney injury, prerenal azotemia, chronic kidney disease, or even normal kidney function, can be evaluated based on the single measurements of urinary or circulating NGAL, and serum or plasma creatinine. Urinary NGAL level is highly predictive of clinical outcomes, including nephrology consultation, dialysis, and admission to the intensive care unit.
REFERENCES:
patent: 6136526 (2000-10-01), Venge
patent: 2004/0219603 (2004-11-01), Devarajan et al.
patent: 2005/0272101 (2005-12-01), Devarajan et al.
patent: 2009/0170143 (2009-07-01), Uttenthal et al.
patent: WO 2004/005544 (2004-01-01), None
patent: WO 2006/066587 (2006-06-01), None
patent: WO 2007/137582 (2007-12-01), None
patent: WO 2007/137584 (2007-12-01), None
patent: WO 2008/017306 (2008-02-01), None
Devarajan, P, Novel biomarkers for the early prediction of acute kidney injury; Cancer Therapy, vol. 3, Sep. 2005, pp. 477-488.
Kjeldsen, L, et al., Characterization of two ELISAs for NGAL, a newly described lipocalin in human neutrophils, Journal of Immunological Methods 198, Nov. 1996, pp. 155-164.
Matthaeus, T, et al., Acute Ischemic Renal Failure Induces Expression of Neutrophil Gelatinase-Associated Lipocalin and Matrix Metalloproteinase-9 in Damaged Tubuli, Kidney Blood Press Res, vol. 24, Congress of Nephrology, Sep./Oct. 2001, p. 342 (2 pages).
Matthaeus, T, et al., Co-Regulation of Neutrophil Gelatinase-Associated Lipocalin and Matrix Metalloproteinase-9 in the Postischemic Rat Kidney, J Am Soc Nephrol vol. 12, Sep. 2001, Pathophysiology of Renal Disease: Acute Renal Failure, pp. 787A; A4112 (1 page).
Mishra, J, et al., Identification of Neutrophil Gelatinase-Associated Lipocalin as a Novel Early Urinary Biomarker for Ischemic Renal Injury, J Am Soc Nephrol, vol. 14, Oct. 2003, pp. 2534-2543.
Mishra, J, et al., Amelioration of Ischemic Acute Renal Injury by Neutrophil Gelatinase-Associated Lipocalin; J. Am. Soc Nephrol, vol. 15, Dec. 2004, pp. 3073-3082.
Mishra, J, et al., Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery, The Lancet, vol. 365, Apr. 2, 2005, pp. 1231-1238.
Mishra, J, et al., Neutrophil Gelatinase-Associated Lipocalin: A Novel Early Urinary Biomarker for Cisplatin Nephrotoxicity, Am J Nephrol, vol. 24, May 2004, pp. 307-315.
Ohlsson, S, et al., Increased Ciruculating Levels of Proteinase 3 in Patients with Anti-Neutrophilic Cytoplasmic Autoantibodies-Associated Systemic Vasculitis in Remission, Clin Exp Immunol, vol. 131, Mar. 2003, pp. 528-535.
Bellomo, R, et al., Acute Dialysis Quality Initiative Workgroup. Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group, Crit Care, vol. 8, 2004; pp. R204-212.
Bonventre, J V, et al., Recent advances in the pathophysiology of ischemic acute renal failure, J Am Soc Nephrol, vol. 14, 2003, pp. 2199-2210.
Chertow, G M, et al., Acute kidney injury, mortality, length of stay, and costs in hospitalized patients, J Am Soc Nephrol, vol. 16, 2005, pp. 3365-3370.
Dent, C L, et al., Plasma neutrophil gelatinase-associated lipocalin predicts acute kidney injury, morbidity and mortality after pediatric cardiac surgery: a prospective uncontrolled cohort study, BioMed Central Ltd, Dec. 2007, http://ccforum.com/content/11/6/R127, (8 pages).
Devarajan, P, et al., The von Hippel-Lindau Gene Product Inhibits Renal Cell Apoptosis via Bcl-2-dependent Pathways, The Journal of Biological Chemistry,vol. 276, No. 44, Nov. 2, 2001, pp. 40599-40605.
Gottlieb, S S, et al., The prognostic importance of different definitions of worsening renal function in congestive heart failure, Journal of Cardiac Failure, vol. 8, No. 3, 2002, pp. 136-141.
Han, W K, et al., Urinary biomarkers in the early diagnosis of acute kidney injury, Kidney International, http://kidney.international.org, 2007, pp. 1-7.
Han, W K, et al., Kidney Injury Molecule-1(KIM-1): A novel biomarker for human renal proximal tubule injury; Kidney International, vol. 62, Jul. 2002, pp. 237-244.
Herget-Rosenthal, S, et al., Early detection of acute renal failure by serum cystatin C, Kidney International, vol. 66, Issue 3, Sep. 2004, pp. 1115-1122.
Hirsch, R, et al., NGAL is an early predictive biomarker of contrast-induced nephropathy in children, Pediatr Nephrol, DOI 10.1007/s00467-007-0601-4, Jul. 2007 (7 pages).
Ichimura, T, et al., Kidney Injury Molecule-1 (KIM-1), a Putative Epithelial Cell Adhesion Molecule Containing a Novel Immunoglobulin Domain, Is Up-regulated in Renal Cells after Injury, The Journal for Biological Chemistry, vol. 273, No. 7, Feb. 13, 1998, pp. 4135-4142.
Kjeldsen, L, et al., Human neutrophil gelatinase-associated lipocalin and homologous proteins in rat and mouse, Biochimica et Biophysica Acta 1482, Feb. 10, 2000, pp. 272-283.
Kjeldsen, L, et al., Isolation and Primary Structure of NGAL, a Novel Protein Associated with Human Neutrophil Gelatinase, The Journal of Biological Chemistry, vol. 268, No. 14, May 15, 1993, pp. 10425-10432.
Lameire, N, et al., Reflections on the definition, classification, and diagnostic evaluation of acute renal failure [Editorial], Current Opinion in Critical Care,vol. 10, 2004, pp. 468-475.
Lassnigg, A, et al., Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study, J Am Soc Nephrol, vol. 15, 2004, pp. 1597-1605.
Liangos, O, et al., Urinary N-acetyl-beta-(D)-glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure, J Am Soc Nephrol, vol. 18, 2007, pp. 904-912.
Molitoris, B A, et al, Acute renal failure II. Experimental models of acute renal failure: imperfect but indispensable, Am J Physiol Renal Physiol, vol. 278, Jan. 2000, pp. F1-F12.
Mori, J, et al., Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury, The Journal of Clinical Investigation, vol. 115, No. 3, Mar. 2005, pp. 610-621.
Muramatsu, Y, et al., Early detection of cysteine rich protein 61 (CYR61, CCNI) in urine following renal ischemic reperfusion injury, Kindney International, vol. 62, Nov. 2002, pp. 1601-1610.
Nickolas, T, et al., A Single Measurement of Urine Neutrophil Gelatinase-Associated Lipocalin Indentifies Acute Kidney Injury at Hospital Presentation and Predicts Poor Outcome, Clinical Nephrology: Acute Kidney Injury: Clinical II, Poster Board No. SU-P0953, Nov. 4, 2007 (1 page).
O'Rourke, et al., Urinary Biomarkers of Renal Failure, unpublished-presentation at poster session, Rio de Janeiro, Brazil, May 27, 2007 (18 pages).
Barasch, J, et al., Biomarkers of Renal Disease, unpublished-presentation at seminar, Berlin, Germany, Jun. 22, 2007 (37 pages).
Smith, G L, et al., Worsening Renal Function: What Is a Clinically Meaningful Change in Creatinine During Hospitalization With Heart Failure?, Journal of Cardiac Failure, vol. 9, No. 1, 2003, pp. 13-25.
Schmidt-Ott, K M, et al., Neutrophil gelatinase-associated lipocalin-mediated iron traffic in kidney epithelia, Current Opinion in Nephrology and Hypertension, 2006, pp. 1-8.
Schmidt-Ott, K M, et al., Duel Action of Neutrophil Ge
Barasch Jonathan Matthew
Devarajan Prasad
Nickolas Thomas L.
Children's Hospital Medical Center
Fritchman Rebecca
Hasse & Nesbitt LLC
Kim Vickie
Nesbitt Daniel F.
LandOfFree
Method for distinguishing between kidney dysfunctions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for distinguishing between kidney dysfunctions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for distinguishing between kidney dysfunctions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2738041